Pharmaceutical Giants Challenge Delaware Court Over Expert Testimony in Zantac Case, Fear Increase in Mass Tort Filings
Dover, Delaware — Leading pharmaceutical giants are urging Delaware’s highest court to reconsider a lower court’s decision that greenlit expert testimony in ongoing Zantac litigation, claiming the ruling misaligns with established federal standards. Companies like GlaxoSmithKline, Pfizer, Sanofi, and Boehringer Ingelheim, which are part of the lawsuit focused on the heartburn medication Zantac, fear it could transform Delaware into a hotbed for mass tort litigation. Represented by distinguished law firms including Dechert, Williams & Connolly, DLA Piper, and King & Spalding, these pharmaceutical heavyweights find the Superior Court’s decision unsettling. The ruling by Superior Court … Read more